FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
NMFS closes the Atlantic bluefin tuna angling category trophy fishery in Southern New England for 2026 for fish measuring 73 inches or greater curved fork length.
Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.
CDC seeks public comment on a proposed Management Information System for Comprehensive Cancer Control Programs that will conduct annual key informant interviews and biennial surveys to monitor program outcomes.
EPA accepts public comments on new pesticide product registration applications containing previously unregistered active ingredients, with details on 2025 submissions under Federal Insecticide, Fungicide, and Rodenticide Act procedures.
EPA finalizes hazardous air pollutant emission standards for plywood and composite wood products facilities, setting maximum achievable control technology limits for formaldehyde, acetaldehyde, and other HAP compounds at major source facilities.
FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
CMS proposes 2027 Medicare home health payment rate updates, case-mix recalibrations, quality reporting changes, and DMEPOS enrollment and benefit modifications affecting home health agencies and DME suppliers.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
